Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$0.98 - $1.49 $3,663 - $5,569
3,738 New
3,738 $4,000
Q3 2022

Nov 04, 2022

SELL
$10.22 - $23.7 $9,688 - $22,467
-948 Reduced 41.36%
1,344 $15,000
Q2 2022

Jul 29, 2022

BUY
$4.35 - $15.85 $9,970 - $36,328
2,292 New
2,292 $25,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $46.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.